Michelle Gill is a senior data scientist at BenevolentAI, where she uses artificial intelligence to facilitate pharmaceutical discovery. Previously, Michelle was a deep learning consultant within NVIDIA’s Professional Services Group and a scientist at the National Cancer Institute, where she developed parallelized software utilizing machine learning and compressed sensing algorithms. As a postdoctoral research fellow at Columbia University Medical School, she studied the biological activity of cancer-associated enzymes. She holds a PhD in molecular biophysics and biochemistry from Yale University.